Large neutral amino acids in daily practice

Journal of Inherited Metabolic Disease

Volumn 33, Issue SUPPL. 3, 2010, Pages

  Ahring, Kirsten Kiær ^a  

^a JOHN F KENNEDY INSTITUTE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BIOLOGICAL MARKER; PHENYLALANINE; POWDER; TABLET;

ADULT; AGED; ARTICLE; BLOOD; CASE REPORT; DENMARK; DIET THERAPY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PHENYLKETONURIA; POWDER; PROTEIN RESTRICTION; PSYCHOLOGICAL ASPECT; TABLET; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT; PHENYLKETONURIAS; PSYCHOLOGY;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS, NEUTRAL; BIOLOGICAL MARKERS; COMBINED MODALITY THERAPY; DENMARK; DIET, PROTEIN-RESTRICTED; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENYLALANINE; PHENYLKETONURIAS; POWDERS; TABLETS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84897922519     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9069-7     Document Type: Article

References (12)

1. Andersen AE, Avins L (1976) Lowering brain phenylalanine levels by giving other large neutral amino acids. A new experimental therapeutic approach to phenylketonuria. Arch Neurol 33:684-686
2. Giovannini M, Verduci E, Salvatici E, Fiori L, Riva E (2007) Phenylketonuria: dietary and therapeutic challenges. J Inherit Metab Dis 30:145-152
3. Güttler F, Lou H (1986) Dietary problems of phenylketonuria: effect on CNS transmitters and their possible role in behaviour and neuropsychological function. J Inherit Metab Dis 9(Suppl 2):169-177
4. Güttler F, Wamberg E (1977) Fasting serum phenylalanine in untreated institutionalised patients with phenylketonuria. J Ment Defic Res 21:55-62
5. Kalkanoglu HS, Ahring KK, Sertkaya D et al. (2005) Behavioural effects of phenylalanine-free amino acid tablet supplementation in intellectually disabled adults with untreated phenylketonuria. Acta Paediatr 94:1218-1222
6. Lou H (1985) Large doses of tryptophan and tyrosine as potential therapeutic alternative to dietary phenylalanine restriction in phenylketonuria. Lancet 2:150-151
7. Lou HC, Lykkelund C, Gerdes AM, Udesen H, Bruhn P (1987) Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria. Acta Paediatr Scand 76:560-565
8. Matalon R, Michals-Matalon K, Bhatia G et al. (2006) Large neutral amino acids in the treatment of phenylketonuria (PKU). J Inherit Metab Dis 29:732-738, FF
9. Pietz J, Kreis R, Rupp A et al. (1999) Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest 103:1169-1178
10. Scriver CR (2007) The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat 28:831-845
11. Scriver CR, Kaufman S (2001) Hyperphenylalaninemia:phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet al., Sly WS, Valle D (eds) Childs B, Kinzler KW, Vogelstein B (assoc. eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, Chap. 77, pp 1667-1705
12. Smith QR, Momma S, Aoyagi M, Rapoport SI (1987) Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 49:1651-1658